dr. R. (Rik) Rozemeijer
Research Staff Other
- Radiology
Contact
Research Output (14)
Advances in percutaneous coronary intervention and antiplatelet therapy in ischemic heart disease
Rozemeijer Rik 10 sep 2019, 170 p.
Incidence, angiographic and clinical predictors, and impact of stent thrombosis:a 6-year survey of 6,545 consecutive patients
Rozemeijer R., Wong C. Wing, Leenders G., Timmers L., Koudstaal S., Rittersma S. Z., Kraaijeveld A., Bots M., Doevendans P., Stella P., Voskuil M. 20 mrt 2019, In: Netherlands Heart Journal. 27 , p. 321-329
Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent
Rozemeijer Rik, Stein Mera, Voskuil Michiel, van den Bor Rutger, Frambach Peter, Pereira Bruno, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Agostoni Pierfrancesco, Roes Kit C, Doevendans Pieter A, Stella Pieter R, 2 jan 2019, In: Circulation. 139 , p. 67-77 11 p.
One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents:A propensity-score adjusted analysis
Rozemeijer Rik, van Muiden Ivar G, Koudstaal Stefan, Leenders Geert E, Timmers Leo, Rittersma Saskia Z, Kraaijeveld Adriaan O, Doevendans Pieter A, Voskuil Michiel, Stella Pieter R 2 jan 2019, In: Catheterization and Cardiovascular Interventions. 94 , p. 61-69 9 p.
Duration of dual antiplatelet therapy after percutaneous coronary intervention:Is less more?
Rozemeijer Rik, Van Bezouwen Wijnand P., Voskuil Michiel, Stella Pieter R. 1 dec 2018, In: US Cardiology Review. 12 , p. 91-97 7 p.
Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents:A single-center registry
Rozemeijer Rik, Benedetto Daniela, Kraaijeveld Adriaan O., Voskuil Michiel, Stein Mèra, Timmers Leo, Rittersma Saskia Z., Agostoni Pierfrancesco, Doevendans Pieter A., Stella Pieter R. jul 2018, In: Cardiovascular revascularization medicine : including molecular interventions. 19 , p. 521-525
Short versus long duration of dual antiplatelet therapy following drug-eluting stents:a meta-analysis of randomised trials
Rozemeijer R, Voskuil M, Greving J P, Bots M L, Doevendans P A, Stella P R mei 2018, In: Netherlands Heart Journal. 26 , p. 242-251
Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial:A multicenter randomized clinical trial
Rozemeijer Rik, Stein Mèra, Frambach Peter, Voskuil Michiel, Kraaijeveld Adriaan O, Rodríguez-Olivares Ramón, Timmers Leo, Pereira Bruno, Rittersma Saskia, Agostoni Pierfrancesco, Doevendans Pieter A, Stella Pieter R 15 feb 2018, In: Catheterization and Cardiovascular Interventions. 91 , p. 410-416
Short versus long DAPT following PCI, a systematic review and meta-analysis
Rozemeijer Rik, Voskuil Michiel, Stella Pieter 31 okt 2017, In: Journal of the American College of Cardiology. 70 , p. B226-B227 2 p.
Effect of body mass index on clinical outcome and all-cause mortality in patients undergoing transcatheter aortic valve implantation
Abawi M., Rozemeijer R., Agostoni P., van Jaarsveld R. C., van Dongen C S, Voskuil M., Kraaijeveld A. O., Doevendans P. A.F.M., Stella P. R. sep 2017, In: Netherlands Heart Journal. 25 , p. 498-509 12 p.